Labrys Biologics
Latest round
- Series A
Last raised
- Jan 2013
Total raised
- $31M
Investors
- 4
About Labrys Biologics
Labrys Biologics, Inc. is a development stage biotechnology company focused on treatments for chronic migraine.
Who invested in Labrys Biologics
4 investors across 2 rounds
See all investors in Labrys Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Labrys Biologics
Who invested in Labrys Biologics?
Labrys Biologics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Labrys Biologics raised?
Labrys Biologics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Labrys Biologics last raise money?
Labrys Biologics's most recent round on record is a Series A, in Jan 2013.
What does Labrys Biologics do?
Labrys Biologics is a biotechnology company.
Where is Labrys Biologics headquartered?
Labrys Biologics is headquartered in San Mateo, US.
Which VCs invest in companies like Labrys Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Labrys Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Labrys Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.